Medidata Solutions Inc (NASDAQ:MDSO) has received an average rating of “Buy” from the seventeen ratings firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $87.75.
A number of analysts recently commented on MDSO shares. Zacks Investment Research lowered Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, April 12th. Piper Jaffray Companies boosted their price objective on Medidata Solutions to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, May 23rd. Deutsche Bank boosted their price objective on Medidata Solutions from $78.00 to $85.00 and gave the stock a “buy” rating in a report on Thursday, May 31st. Morgan Stanley lowered Medidata Solutions from an “overweight” rating to a “hold” rating and set a $79.00 price objective for the company. in a report on Monday, May 21st. Finally, Needham & Company LLC boosted their price objective on Medidata Solutions to $80.00 and gave the stock a “buy” rating in a report on Friday, April 20th.
In related news, Director Lee Shapiro sold 12,500 shares of the company’s stock in a transaction that occurred on Thursday, July 26th. The stock was sold at an average price of $76.16, for a total value of $952,000.00. Following the transaction, the director now owns 26,028 shares in the company, valued at $1,982,292.48. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Rouven Bergmann sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, July 19th. The shares were sold at an average price of $85.36, for a total value of $256,080.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,418 shares of company stock valued at $3,086,728. 4.70% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the stock. World Asset Management Inc purchased a new stake in shares of Medidata Solutions in the second quarter worth $235,000. Zeke Capital Advisors LLC purchased a new stake in shares of Medidata Solutions in the second quarter worth $239,000. Asset Management One Co. Ltd. raised its position in shares of Medidata Solutions by 102.7% in the first quarter. Asset Management One Co. Ltd. now owns 3,948 shares of the company’s stock worth $248,000 after buying an additional 2,000 shares in the last quarter. Cornerstone Wealth Management LLC purchased a new stake in shares of Medidata Solutions in the second quarter worth $285,000. Finally, Joel Isaacson & Co. LLC purchased a new stake in shares of Medidata Solutions in the first quarter worth $314,000.
Medidata Solutions traded up $0.07, reaching $76.12, during midday trading on Tuesday, Marketbeat.com reports. The stock had a trading volume of 518,584 shares, compared to its average volume of 981,437. Medidata Solutions has a 12 month low of $59.60 and a 12 month high of $88.87. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 78.40, a PEG ratio of 4.77 and a beta of 1.40. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.41 and a quick ratio of 1.63.
Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, July 24th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. Medidata Solutions had a return on equity of 11.37% and a net margin of 9.13%. The business had revenue of $155.90 million during the quarter, compared to analyst estimates of $155.86 million. During the same period in the previous year, the company posted $0.31 EPS. The firm’s revenue was up 14.6% compared to the same quarter last year. sell-side analysts expect that Medidata Solutions will post 0.79 EPS for the current year.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Further Reading: Outstanding Shares and The Effect on Share Price
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.